Evidence map›Paper›PMID 32098946›Full record

Trial reportTranslational psychiatry2020

High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophrenia.

Heng Yong Guan, Jian Min Zhao, Ke Qiang Wang, Xiu Ru Su, Yan Fen Pan, Jin Ming Guo, Long Jiang, Yu Hong Wang, Hong Yu Liu, Shi Guang Sun and 11 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 5 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Heng Yong GuanHebei Province Rong-Jun Hospital, Baoding, China.
Jian Min ZhaoHebei Province Rong-Jun Hospital, Baoding, China.
Ke Qiang WangHebei Province Rong-Jun Hospital, Baoding, China.
Xiu Ru SuHebei Province Rong-Jun Hospital, Baoding, China.
Yan Fen PanHebei Province Rong-Jun Hospital, Baoding, China.
Jin Ming GuoHebei Province Rong-Jun Hospital, Baoding, China.
Long JiangHebei Province Rong-Jun Hospital, Baoding, China.
Yu Hong WangHebei Province Rong-Jun Hospital, Baoding, China.
Hong Yu LiuHebei Province Rong-Jun Hospital, Baoding, China.
Shi Guang SunHebei Province Rong-Jun Hospital, Baoding, China.
Hao Ran WuHebei Province Rong-Jun Hospital, Baoding, China.
Yan Ping RenThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
Han Song GengHebei Province Rong-Jun Hospital, Baoding, China.
Xiao Wen LiuHebei Province Rong-Jun Hospital, Baoding, China.
Hui Jing YuHebei Province Rong-Jun Hospital, Baoding, China.
Bao Chun WeiHebei Province Rong-Jun Hospital, Baoding, China.
Xi Po LiHebei Province Rong-Jun Hospital, Baoding, China.
Hanjing Emily WuDepartment of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.
Shu Ping TanPeking University Huilongguan Clinical Medical School, Beijing Huilongguan Hospital, Beijing, China.
Mei Hong XiuPeking University Huilongguan Clinical Medical School, Beijing Huilongguan Hospital, Beijing, China. xiumeihong97@163.com.
Xiang Yang ZhangDepartment of Psychology, University of Chinese Academy of Sciences, Beijing, China. zhangxy@psych.ac.cn.
Hospital of Hebei Province · CNPeking University · CNBaylor College of Medicine · USBeijing Anding Hospital · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive impairment is a central aspect of schizophrenia (SCZ) that occurs at the onset of the disease and is related to poor social function and outcome in patients with SCZ. Recent literatures have revealed repetitive transcranial magnetic stimulation (rTMS) to be one of the efficient medical interventions for cognitive impairments. However, no study has been conducted to investigate the treatment effectiveness of 20 Hz rTMS with neuronavigation system administered to the left dorsolateral prefrontal cortex (DLPFC) in patients with schizophrenia. In this randomized, double-blind and sham-controlled study, 56 patients were enrolled in 20 Hz rTMS (n = 28) or sham stimulation (n = 28) over left DLPFC for 8 weeks. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was performed to measure the cognitive function at baseline and after 8 weeks of rTMS treatment. The positive and negative syndrome scales (PANSS) was performed to assess the clinical symptoms at baseline, after 2-week treatment, 4-week treatment, 6-week treatment, and 8-week treatment. Totally, 15 subjects (seven in active group and eight in sham group) dropped out during the trial and the main findings were from completed 41 patients. At 2 weeks, 4 weeks, and 6 weeks, there were no significant differences in PANSS total score and subscores between the sham and treatment groups. At 8 weeks, the 20 Hz rTMS significantly increased the immediate memory score compared with the sham. Furthermore, the improvement in the immediate memory score was correlated with the decrease in the excitement factor score of the patients with SCZ. Our results suggest that 20 Hz rTMS appears to be an effective treatment for improving the cognitive performance and reducing the clinical symptoms of patients with SCZ.

Indexed as

Cognitive DysfunctionSchizophreniaVeteransDouble-Blind MethodHumansPrefrontal CortexTranscranial Magnetic StimulationTreatment Outcome

Identifiers

PMID32098946
PMCPMC7042343
OpenAlexW3007969428

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.